In the TNM classification system, assessments of the primary tumor (T), lymph node involvement (N), and distant metastases (M) are combined with serum tumor marker values (S) like AFP, beta-HCG, and LDH to define prognostic stage groups from I to III. The treatment plan, including chemotherapy and radiotherapy, depends upon the stage of the tumor diagnosed.

**AJCC TNM staging classification 8th ed., 2017**

**Definitions for T, N, M:**

Pathological T

- Tx Primary tumor cannot be assessed

- T0 No evidence of primary tumor

- Tis Germ cell neoplasia in situ

- T1 Tumor limited to the testicle (including rete testis invasion) without lymphovascular invasion

- T1a Tumor smaller than 3 cm in size

- T1b Tumor 3 cm or larger

- T2 Tumor limited to the testicle (including rete testis invasion) with lymphovascular invasion or tumor invading hilar soft tissue or epididymis or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion

- T3 Tumor directly invades spermatic cord soft tissue with or without lymphovascular invasion

- T4 Tumor invades scrotum with or without lymphovascular invasion

Clinical N

- Nx Regional lymph nodes cannot be assessed

- N0 No regional lymph node metastasis

- N1 Metastasis with a lymph node mass 2 cm or smaller in greatest dimension or multiple lymph nodes, none larger than 2 cm in greatest dimension

- N2 Metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension or multiple lymph nodes, if any mass larger than 2 cm but not larger than 5 cm in greatest dimension

- N3 Metastasis with a lymph node mass larger than 5 cm in greatest dimension

Pathological N

- Nx Regional lymph nodes cannot be assessed

- N0 No regional lymph node metastasis

- N1 Metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension

- N2 Metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor

- N3 Metastasis with a lymph node mass larger than 5 cm in greatest dimension

Clinical or pathological M

- M0 No distant metastases

- M1 Distant metastases

- M1a Non-retroperitoneal nodal or pulmonary metastases

- M1b Non-pulmonary visceral metastases

Serum markers S

- Sx Marker studies not available or not performed

- S0 Marker study levels within normal limits

- S1 LDH <1.5 x N* and hCG (mIU/mL) <5,000 and AFP (ng/mL) <1,000

- S2 LDH 1.5–10 x N* or hCG (mIU/mL) 5,000–50,000 or AFP (ng/mL) 1,000 to 10,000

- S3 LDH >10 x N* or hCG (mIU/mL) >50,000 or AFP (ng/mL) >10,000

**AJCC prognostic stage groups**

- **Stage 0**pTis N0 M0 S0

- **Stage I**pT1-T4 N0 M0 Sx

- **Stage IA**pT1 N0 M0 S0

- **Stage IB**pT2 N0 M0 S0               pT3 N0 M0 S0               pT4 N0 M0 S0

- **Stage IS**Any pT/Tx N0 M0 S1-3

- **Stage II**Any pT/Tx N1-3 M0 Sx

- **Stage IIA**Any pT/Tx N1 M0 S0                Any pT/Tx N1 M0 S1

- **Stage IIB**Any pT/Tx N2 M0 S0                Any pT/Tx N2 M0 S1

- **Stage IIC**Any pT/Tx N3 M0 S0                Any pT/Tx N3 M0 S1

- **Stage III**Any pT/Tx Any N M1 SX

- **Stage IIIA**Any pT/Tx Any N M1a S0                  Any pT/Tx Any N M1a S1

- **Stage IIIB**Any pT/Tx N1-3 M0 S2                  Any pT/Tx Any N M1a S2

- **Stage IIIC**Any pT/Tx N1-3 M0 S3                  Any pT/Tx Any N M1a S3                  Any pT/Tx Any N M1b Any S

*Serum tumor marker values (S) are measured after orchiectomy.